Innovation
3 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 35 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
R&D manufacturer of drugs for multiple therapeutic areas
3 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 35 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |